Superworth

Jade Biosciences EPS JBIO

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Last 12 months, to Jun 30, 2026
−$2.31
Latest quarter, Q2 FY26
−$0.76
Fiscal year 2025
−$13.94

Jade Biosciences' earnings per share was −$2.31 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.76.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$13.94n/a
FY2024−$70.96n/a
FY2023−$100.80n/a
FY2022−$73.85n/a
FY2021−$1256.15n/a
FY2020−$1409.80n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.76n/a−$2.31
Q1 FY26−$0.57n/a−$2.41
Q4 FY25−$0.50n/a−$13.94
Q3 FY25−$0.48n/a−$20.09
Q2 FY25−$0.86n/a−$24.77
Q1 FY25−$12.10n/a−$54.01
Q4 FY24−$6.65n/a−$70.96
Q3 FY24−$5.16n/a−$90.21
Q2 FY24−$30.10n/a−$109.90
Q1 FY24−$29.05n/a−$106.40
Q4 FY23−$25.90n/a−$100.80
Q3 FY23−$24.85n/a−$96.25

Against its peers

Companies in Drug Manufacturers - General nearest Jade Biosciences' size, closest first, today.

CompanyEPS, 12 monthsGrowth
JBIOJade Biosciences−$2.31
ABUSArbutus Biopharma$0.78
AMPHAmphastar Pharmaceuticals$1.70−36% a year
COLLCollegium Pharmaceutical$1.24+19% a year
OMEROmeros$1.52
CRMDCorMedix$2.13+184% a year
PCRXPacira BioSciences$0.35
ANABAnaptysbio$4.57
ZVRAZevra Therapeutics$0.93
IRWDIronwood Pharmaceuticals$0.77
PBYIPuma Biotechnology$0.52−47% a year
Peer median$1.08

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Jade Biosciences

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.